Skip to main content
AAPL $255.31 +1.24% MSFT $401.20 -0.93% GOOGL $306.49 -1.35% AMZN $210.15 +0.47% NVDA $184.07 +1.43% TSLA $396.08 -0.83% META $626.06 -1.32% JPM $286.10 -1.32% V $308.33 +0.00% WMT $125.77 +0.95% AAPL $255.31 +1.24% MSFT $401.20 -0.93% GOOGL $306.49 -1.35% AMZN $210.15 +0.47% NVDA $184.07 +1.43% TSLA $396.08 -0.83% META $626.06 -1.32% JPM $286.10 -1.32% V $308.33 +0.00% WMT $125.77 +0.95%

NASDAQ: TECH

Bio-Techne Corporation

Healthcare • Biotechnology • www.bio-techne.com

$51.47 $-0.36 (-0.70%)

As of Mar 13, 2:24 PM UTC

TECH Latest News

Why Is Techne (TECH) Down 15.1% Since Last Earnings Report?
7 days ago | Yahoo
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
1 week ago | Yahoo
Bio-Techne Corporation (TECH) Presents at TD Cowen 46th Annual Health Care Conference Transcript
1 week ago | SeekingAlpha
Will Ella CE-IVD Approval in EU Clinical Labs Change Bio-Techne's (TECH) Diagnostic Platform Narrative?
2 weeks ago | Yahoo
3 Small-Cap Stocks We Keep Off Our Radar
2 weeks ago | Yahoo
Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections
2 weeks ago | Yahoo
Bio-Techne to Present at Upcoming Investor Conferences
2 weeks ago | Yahoo
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know
3 weeks ago | Yahoo
Evaluating Bio-Techne (TECH) After Ella’s CE-IVD Milestone And Diagnostics Growth Prospects
3 weeks ago | Yahoo
KMDA or TECH: Which Is the Better Value Stock Right Now?
3 weeks ago | Yahoo
Reported Monday, Bio-Techne Announces Ella Benchtop Immunoassay Platform Now CE-IVD Marked And Available For Sale Across The European Union
3 weeks ago | Benzinga
1 Profitable Stock to Target This Week and 2 We Avoid
3 weeks ago | Yahoo
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories
4 weeks ago | Yahoo
There May Be Reason For Hope In Bio-Techne's (NASDAQ:TECH) Disappointing Earnings
4 weeks ago | Yahoo
What Are Wall Street Analysts' Target Price for Bio-Techne Stock?
4 weeks ago | Yahoo
Bio-Techne Announces Changes to its Leadership Team
4 weeks ago | Yahoo
Bio-Techne Corp (NASDAQ:TECH) Passes Key Quality Investing Screen
1 month ago | ChartMill
5 Insightful Analyst Questions From Bio-Techne’s Q4 Earnings Call
1 month ago | Yahoo
How Flat Sales, Higher EPS, and New Organoid Tools At Bio-Techne (TECH) Have Changed Its Investment Story
1 month ago | Yahoo
Wells Fargo Maintains Overweight on Bio-Techne, Raises Price Target to $76
1 month ago | Benzinga
7 Analysts Assess Bio-Techne: What You Need To Know
1 month ago | Benzinga
Citigroup Maintains Buy on Bio-Techne, Raises Price Target to $80
1 month ago | Benzinga
Stifel Maintains Hold on Bio-Techne, Raises Price Target to $65
1 month ago | Benzinga
TD Cowen Maintains Buy on Bio-Techne, Raises Price Target to $80
1 month ago | Benzinga
UBS Maintains Buy on Bio-Techne, Raises Price Target to $79
1 month ago | Benzinga
Evercore ISI Group Maintains In-Line on Bio-Techne, Raises Price Target to $68
1 month ago | Benzinga
TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets
1 month ago | Yahoo
Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion ...
1 month ago | Yahoo
Bio-Techne Q2 Earnings Call Highlights
1 month ago | Yahoo
Bio-Techne (TECH) Q2 2026 Earnings Call Transcript
1 month ago | Yahoo
Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
1 month ago | Yahoo
Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript
1 month ago | SeekingAlpha
Techne (TECH) Beats Q2 Earnings and Revenue Estimates
1 month ago | Yahoo
Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales
1 month ago | Yahoo
Bio-Techne Releases Second Quarter Fiscal 2026 Results
1 month ago | Yahoo
Bio-Techne Declares Dividend
1 month ago | Yahoo
Is Bio-Techne (TECH) Fairly Priced After Recent Share Price Rebound?
1 month ago | Yahoo
Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect
1 month ago | Yahoo
A Look At Bio Techne (TECH) Valuation After Cultrex Synthetic Hydrogel Launch
1 month ago | Yahoo
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
1 month ago | Yahoo
Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock?
1 month ago | Yahoo
Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers
1 month ago | Yahoo
How Investors May Respond To Bio-Techne (TECH) Doubling Down On Multi-Omic Integration Under New Leadership
2 months ago | Yahoo
1 High-Flying Stock for Long-Term Investors and 2 That Underwhelm
2 months ago | Yahoo
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
2 months ago | Yahoo
Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2 months ago | SeekingAlpha
Here's What to Expect From Bio-Techne's Next Earnings Report
2 months ago | Yahoo
A Look At Bio-Techne (TECH) Valuation After Analyst Downgrade And Softer Cash Flow Concerns
2 months ago | Yahoo
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
2 months ago | Yahoo
Bio-Techne Corp. stock outperforms competitors on strong trading day
2 months ago | MarketWatch

FEATURED BY